Terms: = Kidney tumors AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
27 results:
1. Neoplastic Progression of Barrett's Esophagus Among Organ Transplant Recipients: a Retrospective Cohort Study.
Patel V; Sanaka MR; Qin Y; McMichael J; Bena J; Beveridge C; Barron J; Raja S; Modaresi Esfeh J; Thota PN
J Gastrointest Surg; 2023 Sep; 27(9):1785-1793. PubMed ID: 37268829
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials.
Zhu J; Leng X; Gao B; Wang B; Zhang H; Wu L; Ma J; Tan Y; Peng L; Han Y; Wang Q
Front Immunol; 2022; 13():1041233. PubMed ID: 36591306
[TBL] [Abstract] [Full Text] [Related]
3. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
[TBL] [Abstract] [Full Text] [Related]
4. CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma.
Li W; Song YY; Rao T; Yu WM; Ruan Y; Ning JZ; Yao XB; Yang SY; Cheng F
J Cell Mol Med; 2022 Mar; 26(6):1729-1741. PubMed ID: 33560588
[TBL] [Abstract] [Full Text] [Related]
5. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
6. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Sadhukhan P; Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():129-140. PubMed ID: 30948047
[TBL] [Abstract] [Full Text] [Related]
7. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
Ramay FH; Vareedayah AA; Visrodia K; Iyer PG; Wang KK; Eluri S; Shaheen NJ; Reddy R; Martin LW; Greenwald BD; Edwards MA
Ann Surg Oncol; 2019 Mar; 26(3):714-731. PubMed ID: 30607765
[TBL] [Abstract] [Full Text] [Related]
8. Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate.
Chappell JC; Turner PK; Pak YA; Bacon J; Chiang AY; Royalty J; Hall SD; Kulanthaivel P; Bonventre JV
Clin Pharmacol Ther; 2019 May; 105(5):1187-1195. PubMed ID: 30449032
[TBL] [Abstract] [Full Text] [Related]
9. Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway.
Sim MY; Yuen JSP; Go ML
Sci Rep; 2018 Jul; 8(1):10289. PubMed ID: 29980758
[TBL] [Abstract] [Full Text] [Related]
10. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract] [Full Text] [Related]
11. Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.
Sim MY; Huynh H; Go ML; Yuen JSP
PLoS One; 2017; 12(6):e0178168. PubMed ID: 28582447
[TBL] [Abstract] [Full Text] [Related]
12. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of radiofrequency ablation of small renal tumors in patients at high anesthetic and surgical risk: urologist experience with follow-up results in the initial six months.
Yuksel MB; Karakose A; Gumus B; Tarhan S; Atesci YZ; Akan Z
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6637-41. PubMed ID: 24377580
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic correlation between the expression of the DNA repair enzyme N-methylpurine DNA glycosylase and esophageal adenocarcinoma onset: a retrospective pilot study.
Zaïr ZM; Johnson GE; Griffiths AP; Jenkins GJ
Dis Esophagus; 2013 Aug; 26(6):644-50. PubMed ID: 23137018
[TBL] [Abstract] [Full Text] [Related]
16. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
[TBL] [Abstract] [Full Text] [Related]
17. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.
Orloff M; Peterson C; He X; Ganapathi S; Heald B; Yang YR; Bebek G; Romigh T; Song JH; Wu W; David S; Cheng Y; Meltzer SJ; Eng C
JAMA; 2011 Jul; 306(4):410-9. PubMed ID: 21791690
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses.
Quaia E; Bertolotto M; Cioffi V; Rossi A; Baratella E; Pizzolato R; Cov MA
AJR Am J Roentgenol; 2008 Oct; 191(4):1239-49. PubMed ID: 18806171
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract] [Full Text] [Related]
20. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
[TBL] [Abstract] [Full Text] [Related]
[Next]
